Dr. Reddy's Laboratories informs about press release

04 Sep 2021 Evaluate

Dr. Reddy's Laboratories has informed that it enclosed a Press Release on 4th September titled ‘Dr. Reddy's Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)’.

The above information is a part of company’s filings submitted to BSE.


Dr. Reddys Lab Share Price

1287.20 -31.70 (-2.40%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×